The interface between apoptosis (programmed cell death) and the cell cycle is essential to preserve homeostasis and genomic integrity. Here, we show that survivin, an inhibitor of apoptosis over-expressed in cancer, physically associates with the cyclindependent kinase p34 cdc2 on the mitotic apparatus, and is phosphorylated on Thr 34 by p34 cdc2 -cyclin B1, in vitro and in vivo. Loss of phosphorylation on Thr 34 resulted in dissociation of a survivincaspase-9 complex on the mitotic apparatus, and caspase-9-dependent apoptosis of cells traversing mitosis. These data identify survivin as a mitotic substrate of p34 cdc2 -cyclin B1 and suggest that survivin phosphorylation on Thr 34 may be required to preserve cell viability at cell division. Manipulation of this pathway may facilitate the elimination of cancer cells at mitosis.
A poptosis or programmed cell death couples to surveillance mechanisms, i.e., checkpoints, to eliminate unneeded, damaged, and potentially harmful cells (1) . This process requires the assembly of an evolutionary conserved ''apoptosome'' complex, which comprises the upstream cell death protease caspase-9, the adapter͞cofactor protein Apaf-1, mitochondria-derived cytochrome c and ATP͞dATP, and culminates with downstream activation of effector caspases (2) . A similar paradigm linking apoptosis control to surveillance mechanisms has been extended to checkpoint presiding over cell cycle transitions (3) , which, at mitosis, control the assembly of a bipolar mitotic apparatus, preservation of ploidy, and timing of cytokinesis (4) .
A candidate molecule for the interface between apoptosis and cell cycle was recently identified as survivin (5) , a member of the inhibitor of apoptosis (IAP) gene family (6) , selectively expressed at G 2 ͞M and localized to mitotic spindle microtubules (7) . Antisense targeting of survivin resulted in increased caspase-3 activity at mitosis (7) , with spontaneous apoptosis and dysregulation of mitotic progression (8) , whereas interference with survivin homologs in Caenorhabditis elegans and yeast caused a lethal defect of cytokinesis (9, 10) . Altogether, these data suggested a role of survivin in maintaining cell viability at mitosis, potentially coupling apoptosis control to regulation of cell division. This pathway may be dramatically exploited in cancer, where survivin was identified as the top fourth ''transcriptome'' expressed in human tumors, but not in normal tissues (11) . Here, we investigated the potential requirements of survivin regulation of apoptosis at cell division.
Materials and Methods
Cells and Antibodies. HeLa cells were from American Type Culture Collection. YUSAC2 melanoma cells were characterized previously (12) . Cell-cycle synchronization was carried out as described (7) . The antibodies to survivin were described previously (7, 12) . A rabbit antibody was raised against the survivin peptide L 28 EGCACT*PERMAEAGFI 44 containing phosphorylated Thr 34 (T*). The serum was precleared over a nonphosphorylated peptide-Sepharose column, and unbound material was affinity-purified over a phosphorylated peptideSepharose column. Rabbit antibodies to caspase-9, p34 cdc2 , and Cdk2 were from PharMingen, Zymed, and Santa Cruz Biotechnology, respectively. A rat antibody to hemagglutinin epitope (HA) was from Roche Molecular Biochemicals.
Plasmids, Recombinant Proteins, and Transfections. Site-directed mutagenesis of the survivin cDNA (5) with generation of survivin(T34A) in pEGFPc1 and pcDNA3, with or without HA tag, was carried out by using the GeneEditor system (Promega) (8) . A caspase 9 dominant negative mutant (Cys 287 3Ala) was generated by overlapping PCR and directionally cloned in pcDNA3 or pEGFPc1. A kinase-dead p34 cdc2 (Asp 146 3Asn) mutant was generated as described (13) , and inserted in pcDNA3. All mutant constructs were confirmed by DNA sequencing. Wild-type survivin or survivin(T34A) were expressed as glutathione S-transferase (GST) fusion proteins in BL21 Escherichia coli, isolated by affinity chromatography on GSTSepharose and released from the GST frame by cleavage with thrombin (1 unit͞ml) overnight (7) . Transient transfections were carried out by Lipofectamine, as described (7, 8) . Comparable expression of the various transfected constructs in HeLa cells was confirmed by flow cytometry by gating on the green f luorescent protein (GFP)-expressing population. A survivin(T34A) cDNA was inserted into pTet-splice, transfected (0.8 g) in YUSAC2 cells with 0.8 g of the transactivation͞ selection plasmid ptTA-Neo by Lipofectamine. Stable lines were selected in 1.5 mg͞ml Geneticin (G418; Life Technologies, Grand Island, NY), 2 mM sodium hydroxide, and 0.5 g͞ml Tet (Sigma). Three clones were isolated for differential growth in the presence or absence of Tet, recloned by limiting dilution, and one of them (YUSAC2͞T34A-C4) was selected for further investigation.
Immunoprecipitation and Western Blotting. Two-hundred micrograms of precleared, detergent-solubilized HeLa cell extracts were immunoprecipitated with antibodies to p34 cdc2 (5 g͞ml), Cdk2 (5 g͞ml), survivin (12) (20 g͞ml), or HA (2.5 g͞ml) for 16 h at 4°C, with precipitation of the immune complexes by addition of 50 l of a 50:50 protein A slurry. After separation by SDS gel electrophoresis, samples were transferred to nylon membranes and incubated with antibodies to p34 Nuclear) in 10% phosphate-free serum, detergent-solubilized, and immunoprecipitated with an antibody to HA (2.5 g͞ml) or control IgG, followed by autoradiography. DNA content analysis by propidium iodide staining, scoring of apoptotic nuclei by 4Ј,6-diamidino-2-phenylindole (DAPI) staining, and double immunofluorescence labeling and confocal microscopy were carried out as described (7, 8) . In some experiments, HeLa cells were treated with 5 M taxol for 18 h at 37°C before labeling for survivin, Thr 34 phosphorylated survivin, and caspase-9 and confocal microscopy analysis. Internucleosomal DNA fragmentation was carried out by end-labeling with terminal deoxynucleotidyl transferase and peroxidase-conjugated anti-digoxigenin antibody, as described (12) .
Results and Discussion
A sequence T 34 PER matching the consensus phosphorylation site (14) for p34 cdc2 is found in human and mouse survivin, but not in other IAP proteins (6) . In in vitro kinase assays, baculovirus-expressed p34 cdc2 -cyclin B1 readily phosphorylated histone H1 and wild-type survivin, whereas substitution of Thr 34 3Ala, i.e., survivin(T34A), abolished phosphorylation by p34 cdc2 -cyclin B1 (Fig. 1A) . In contrast, baculovirus-expressed Cdk2-cyclin E did not phosphorylate wild-type survivin or survivin(T34A) (Fig. 1 A) . A rabbit antibody was raised against the survivin peptide L 28 EGCACT*PERMAEAGFI 44 containing phosphorylated Thr 34 (T*), sequentially affinity purified on nonphosphorylated͞phosphorylated peptide-Sepharose and used in immunoblotting. The antibody to phosphorylated Thr 34 (␣-survivinT34*) recognized wild-type survivin after in vitro phosphorylation by p34 cdc2 -cyclin B1, but not unphosphorylated survivin or survivin(T34A) after incubation with p34 cdc2 -cyclin B1 (Fig. 1B) . In contrast, an antibody to survivin (␣-survivin) (12) indistinguishably recognized wild-type survivin or survivin(T34A), irrespective of Thr 34 phosphorylation (Fig. 1B) . In in vivo experiments, a 16.5-kDa phosphorylated survivin band was immunoprecipitated from orthophosphate-labeled, G 2 ͞M-arrested HeLa cells, whereas no radioactive bands were immunoprecipitated with a control antibody ( Fig. 2A) . Transfection of HeLa cells with a kinase-dead p34 cdc2 mutant (Asp 146 3Asn) (13) nearly completely abolished phosphorylation of endogenous survivin on Thr 34 by Western blotting with ␣-survivinT34* (Fig. 2B) . In control experiments, comparable amounts of endogenous survivin were immunoprecipitated from HeLa cells transfected with control pcDNA3 or p34 cdc2 (Asp 146 3Asn) (Fig.  2B) . We next investigated the kinetics of survivin phosphorylation in vivo. The antibody to phosphorylated Thr 34 did not recognize survivin immunoprecipitated from synchronized HeLa cells at G 1 or S phase 0, 2, and 4 h after thymidine release, respectively (Fig. 2C) . In contrast, phosphorylation of survivin on Thr 34 was detected beginning at 8 h after thymidine release, which coincides with entry into mitosis of these cells by DNA content analysis (7), and remained sustained throughout cell division (Fig. 2C) . In contrast, ␣-survivin recognized survivin immunoprecipitated from synchronized interphase and mitotic HeLa cells (Fig. 2C) . By immunofluorescence and confocal microscopy, both endogenous survivin and phosphorylationdefective survivin(T34A) localized to midbodies at telophase (Fig. 2D) in agreement with previous observations (7). Although endogenous survivin was phosphorylated on Thr 34 on microtubules, no reactivity of ␣-survivinT34* with survivin(T34A) was demonstrated at midbodies by dual immunofluorescence labeling (Fig. 2D) .
We next asked whether survivin and p34 (Fig. 3A) . In contrast, no survivin bands were immunoblotted in p34 cdc2 immunoprecipitates from G 1 -or Ssynchronized cultures (Fig. 3A) . Similarly, Cdk2 immunoprecipitates from synchronized HeLa cells did not contain 16.5-kDa coassociated survivin at any cell cycle phase (Fig. 3A) . In reciprocal experiments, HA-survivin or HA-survivin(T34A) immunoprecipitated from HeLa cells contained coassociated p34 cdc2 by Western blotting (Fig. 3B) , thus demonstrating that a survivin-p34 cdc2 interaction was independent of Thr 34 . Furthermore, endogenous p34 cdc2 and survivin colocalized on mitotic spindle microtubules at prophase and metaphase, and concentrated at midbodies at telophase, by immunofluorescence and confocal microscopy (Fig. 3C) , in agreement with their individual localization (7, 15) . This suggests that a phosphorylationdefective survivin(T34A) mutant may act as a dominant negative mutant for its ability to associate with p34 cdc2 on the mitotic apparatus and prevent phosphorylation of endogenous survivin.
We next investigated a potential role of survivin phosphorylation by p34 cdc2 in apoptosis control and͞or cell cycle progression (8) . In the absence of exogenous apoptotic stimuli, transfection of HeLa cells with survivin(T34A) fused to a GFP caused apoptotic morphology of chromatin condensation and DNA fragmentation in GFP-expressing cells (Fig. 4A) . This was associated with generation of hypodiploid cells by DNA content analysis and flow cytometry, in a reaction reversed by the caspase inhibitor Z-VAD-fmk (Fig. 4B) . Similar results were obtained after transfection of GFP-caspase-9 (Met 1 -Asp 330 ), whereas expression of GFP vector or wild-type survivin did not affect nuclear morphology in HeLa cells (Fig. 4 A and B) . Next, stable lines of survivin-positive YUSAC2 melanoma cells (12) were generated to express survivin(T34A) under the control of a tetracycline (Tet)-regulated promoter (Tet-off system) (16), and one clone (YUSAC2͞T34A-C4) was selected for further investigation. On Tet withdrawal, YUSAC2͞T34A-C4 cells exhibited loss of the mitotic (G 2 ͞M) fraction, appearance of hypodiploid cells, and labeling for internucleosomal DNA fragmentation by TUNEL (Fig. 4C) , thus distinguishing this pathway from mitotic catastrophe at G 2 ͞M (17). In contrast, Tet ϩ YUSAC2͞T34A-C4 cells had normal viability and DNA content, and did not label by TUNEL (Fig. 4C) . To determine the kinetics of apoptosis induced by survivin(T34A) with respect to cell cycle progression, YUSAC2͞T34A-C4 cells were thymidine-synchronized in the presence or absence of Tet, released and analyzed for DNA content at increasing 3-h intervals. Tet ϩ or Tet Ϫ YUSAC2͞ T34A-C4 cells exhibited comparable kinetics of cell cycle progression, approaching the first mitosis 9 h after thymidine release, completing cell division by 15-18 h, and reentering G 1 after 21 h (Fig. 4D) . However, coinciding with entry into mitosis, Tet Ϫ YUSAC2͞T34A-C4 cells began to accumulate within the hypodiploid apoptotic fraction, which increased steadily throughout mitosis and in the postmitotic phase (Fig. 4D) . In contrast, no changes in the hypodiploid fraction were observed in Tet ϩ YUSAC2͞T34A-C4 cells at the various cell cycle phases (Fig. 4D) . Coinciding with entry into mitosis, Tet Ϫ YUSAC2͞ T34A-C4 cells also exhibited progressive proteolytic cleavage of Ϸ46 kDa proform caspase-9 to active subunits of Ϸ35 kDa and Ϸ37 kDa, which peaked in the postmitotic phase with nearly complete disappearance of the Ϸ46-kDa proform band (Fig.  4E) . In contrast, no proteolytic processing of caspase-9 was observed in Tet ϩ YUSAC2͞T34A-C4 cells at the various cell cycle phases (Fig. 4E) .
Next, we asked whether survivin phosphorylation on Thr 34 was required to modulate a potential interaction with effector molecules of apoptosis, and we focused on the intrinsic initiator caspase-9 (18) for its association with survivin in affinity purification experiments (unpublished observations). Immunoprecipitates of HA-survivin from mitotic HeLa cells collected by mitotic shake-off revealed the presence of coassociated Ϸ35- kDa caspase-9, by immunoblotting (Fig. 5A) . In contrast, HAsurvivin(T34A) immmunoprecipitated from mitotic HeLa cells did not contain coassociated caspase-9 (Fig. 5A) . Similar results were obtained in drug-synchronized cultures. HA-survivin immunoprecipitates from mitotic HeLa cells 12 h after thymidine release contained coassociated caspase-9 of Ϸ35 kDa, whereas no caspase-9 bands were coprecipitated with H Asurvivin(T34A) from mitotic HeLa cells (Fig. 5B) . By immunofluorescence and confocal microscopy, HA-survivin and HAsurvivin(T34A) transfected in HeLa cells bound to mitotic spindle microtubules and accumulated at midbodies at telophase, indistinguishably from endogenous survivin (Fig. 5C) , and in agreement with the data presented above. In HA-survivin transfectants, simultaneous labeling for caspase-9 revealed a diffuse cytoplasmic reactivity, and a prominent colocalization between survivin and caspase-9 at midbodies (Fig. 5C ). In contrast, and consistent with the immunoprecipitation experiments described above, caspase-9 did not colocalize with HAsurvivin(T34A) at midbodies (Fig. 5C) . In control experiments, a survivin Leu 64 3Ala mutant did not cause apoptosis (7), and colocalized with caspase-9 at midbodies (Fig. 5C) . Next, we asked whether cell death induced by survivin(T34A) was mediated by mislocalized, active caspase-9. Transfection of HeLa cells with a caspase-9(C287A) dominant negative mutant (19) inhibited nuclear fragmentation and chromatin condensation induced by the anti-cancer drug etoposide, and reversed HeLa cell apoptosis induced by survivin(T34A) (Fig. 5D ). In contrast, cotransfection of HeLa cells with a caspase-8(C360S) dominant negative mutant did not affect apoptosis induced by survivin(T34A), whereas it completely inhibited cell death induced by TNF␣ ϩ cycloheximide (20) (Fig. 5D) .
In summary, these data identify survivin as a mitotic substrate of p34 cdc2 -cyclin B1 (21) , and suggest that survivin phosphorylation on Thr 34 may regulate apoptosis at cell division via an interaction with caspase-9 (2). Although a role of unscheduled p34 cdc2 activity in apoptosis has been debated (22, 23) , the data presented here are consistent with a cytoprotective role of p34 cdc2 , previously suggested from genetic inactivation (24) , or pharmacologic inhibition of the kinase (25) . Similar to other mitotic substrates (26, 27) , phosphorylation by p34 cdc2 may increase the affinity of survivin for active caspase-9, or, alternatively, stabilize survivin or a survivin-caspase-9 anti-apoptotic complex at midbodies during cell division. Based on the survivin crystal structure, Thr 34 is ideally positioned to influence survivin function(s) potentially mediated by the baculovirus IAP repeat (BIR) (28) . Conversely, loss of survivin phosphorylation on Thr 34 resulted in dissociation of a survivin-caspase-9 complex at midbodies and caspase-9-depedent apoptosis at cell division. Although survivin clearly plays an evolutionary conserved role (9, 10) in regulation of mitotic progression and cytokinesis (8) , cells expressing survivin(T34A) progressed through the cell cycle and did not exhibit a G 2 ͞M arrest, as typically seen after interference with regulators of cytokinesis (29, 30) . Taken together with the identification of a Drosophila survivin homolog, Deterin, which acts as a genuine apoptosis inhibitor (31) , these data suggest that survivin may have integrated a primordial role in cell division (9, 10) with a more recent function in apoptosis control at G 2 ͞M. Because of the over-expression of survivin in cancer but not in normal tissues (5, 11) , selective antagonists of survivin phosphorylation by p34 cdc2 may trigger apoptosis of transformed cells and facilitate their elimination at mitosis.
